Söndag 8 December | 10:24:41 Europe / Stockholm

Kalender

Tid*
2025-10-09 N/A Årsstämma
2025-09-11 08:00 Bokslutskommuniké 2025
2025-02-05 17:00 Kvartalsrapport 2025-Q2
2024-10-11 - X-dag ordinarie utdelning CHEMM 4.00 DKK
2024-10-10 - Årsstämma
2024-09-11 - Bokslutskommuniké 2024
2024-02-05 - Kvartalsrapport 2024-Q2
2023-10-13 - X-dag ordinarie utdelning CHEMM 6.00 DKK
2023-10-12 - Årsstämma
2023-09-14 - Bokslutskommuniké 2023
2023-05-09 - 15-10 2023-Q3
2023-02-09 - Kvartalsrapport 2023-Q2
2022-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2022-10-13 - Årsstämma
2022-09-15 - Bokslutskommuniké 2022
2022-02-08 - Kvartalsrapport 2022-Q2
2021-10-15 - X-dag ordinarie utdelning CHEMM 4.00 DKK
2021-10-14 - Årsstämma
2021-09-16 - Bokslutskommuniké 2021
2021-02-05 - Kvartalsrapport 2021-Q2
2020-10-09 - X-dag ordinarie utdelning CHEMM 1.50 DKK
2020-10-08 - Årsstämma
2020-09-17 - Bokslutskommuniké 2020
2020-02-07 - Kvartalsrapport 2020-Q2
2020-01-14 - X-dag bonusutdelning CHEMM 13
2020-01-13 - Extra Bolagsstämma 2020
2019-10-11 - X-dag ordinarie utdelning CHEMM 7.50 DKK
2019-10-10 - Årsstämma
2019-09-17 - Bokslutskommuniké 2019
2019-02-08 - Kvartalsrapport 2019-Q2
2018-10-12 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2018-10-11 - Årsstämma
2018-09-18 - Bokslutskommuniké 2018
2018-02-09 - Kvartalsrapport 2018-Q2
2017-11-15 - Årsstämma
2017-10-13 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2017-10-12 - Årsstämma
2017-09-19 - Bokslutskommuniké 2017
2017-02-10 - Kvartalsrapport 2017-Q2
2016-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2016-10-13 - Årsstämma
2016-09-20 - Bokslutskommuniké 2016
2016-02-26 - Kvartalsrapport 2016-Q2
2015-10-09 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2015-10-08 - Årsstämma
2015-05-15 - Kvartalsrapport 2015-Q3
2014-10-10 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2014-10-09 - Årsstämma
2014-05-15 - Kvartalsrapport 2014-Q3
2013-11-15 - Kvartalsrapport 2014-Q1
2013-10-11 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2013-10-10 - Årsstämma
2013-07-25 - Extra Bolagsstämma 2013
2013-05-14 - Kvartalsrapport 2013-Q3
2012-11-14 - Kvartalsrapport 2013-Q1
2012-10-12 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2012-10-11 - Årsstämma
2012-05-11 - Kvartalsrapport 2012-Q3
2011-11-11 - Kvartalsrapport 2012-Q1
2011-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2011-10-13 - Årsstämma
2011-05-13 - Kvartalsrapport 2011-Q3
2010-11-12 - Kvartalsrapport 2011-Q1
2010-10-06 - X-dag ordinarie utdelning CHEMM 0.00 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
ChemoMetec är verksamt inom medicinteknik. Bolaget är specialiserat inom design, utveckling och produktion av patenterade instrument för cellräkning och cellanalys. Bolaget samarbetar och stadgar avtal med aktörer som forskningsinstitut, universitet, livsmedelsbolag, sjukhus och specialkliniker. Kunderna återfinns på en global marknad. Bolaget grundades ursprungligen 1997 och har sitt huvudkontor i Alleröd, Danmark.
2024-09-20 17:06:56

 

ANNOUNCEMENT NO. 276

20 September 2024

ChemoMetec makes offer to buy Ovizio Imaging Systems SA

ChemoMetec has submitted an indicative offer to buy Belgian company Ovizio Imaging Systems (‘Ovizio’), which has been accepted by the company’s group of owners. ChemoMetec now has three weeks to carry out a due diligence, and if the outcome of this is positive, ChemoMetec will most likely proceed with the acquisition.

Ovizio has developed a cell counter based on holographic microscopy. The instrument is primarily used in bioprocessing and in cell and gene therapy. Ovizio’s product is connected directly to the customers’ bioreactors via a disposable item, which is supplied sterilised and with a high degree of cleanness. With the cell counter, cells can be continuously extracted from the bioreactor for analysis and subsequently returned to the bioreactor.

Ovizio has a number of respected customers in the pharmaceutical and biotech industries. In 2023, the company reported revenue of EUR 1.4 million, of which a substantial part was generated through sales of consumables and service contracts.

ChemoMetec’s Management believes that the technologies and expertise of the two companies will complement each other on the market for automated and integrated cell counting.

At present, it is not possible to assess how a potential acquisition of Ovizio would affect ChemoMetec’s guidance for the 2024/25 financial year.


Additional information

Martin Helbo Behrens, CEO
Tel.: (+45) 48 13 10 20

Kim Nicolajsen, CFO
Tel.: (+45) 48 13 10 20


About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.
ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.